Viking Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $7.1M | $284.3M | $8.4M |
| FY2020 | $12.2M | $256.5M | $29.1M |
| FY2021 | $8.8M | $210.7M | $26.4M |
| FY2022 | $23.2M | $168.5M | $36.6M |
| FY2023 | $20.1M | $368.5M | $55.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $7.1M | $284.3M | $8.4M |
| FY2020 | $12.2M | $256.5M | $29.1M |
| FY2021 | $8.8M | $210.7M | $26.4M |
| FY2022 | $23.2M | $168.5M | $36.6M |
| FY2023 | $20.1M | $368.5M | $55.5M |